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-
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Walt wbltman

CHAPTER I

INTRODUCTION
studies of the cachectical conditions such as
anorexia, weight loss, and MUscular weakness observed
in cancer-bearing animals had long suggested that cancer tissues possibly produced some toxic substance.
The demonstration ot such a substance, however, required an adequate criterion tor its assay.

The dis-

closure ot depressions ot liver catalase activity in
all cancer-bearing animals provided a criterion.
By measuring the liver catalase activity in
laboratory animals injected with a protein traction
extracted trom malignant tissue it was shown that this
extract produced a signiticant decrease in catalase
activity.

The substance responsible tor this effect

was called "toxohormone".
Further investigations disclosed that additional
systemic changes such as decreased plasma iron, kidney catalase, and hemoglobin present in cancer-bearing
animals could be induced in normal animals by the
injection of toxohormone-containlng tumor fractions.
Of these the decrease of blood plasma iron appeared to
-1-

be the most sensitive to the effects 01' toxohormone
and therefore a possible valuable aid tor further
experimentation.
Although research on toxohormone has included
attempts at purification and investigations relating
to mode 01' action, no specific research has been directed toward a comparison 01' the toxohor.mone content 01' malignant tissues.
ties 01' different

sa~ples

Variations in the activiof similarly prepared

toxohormone-containing material have been indirectly
demonstrated, but whether the variations are due to
differences in the toxohormone content among different
types of tumors or cancerous tissues ot varying degrees 01' malignancy are hypotheses which have not
been investigated.

In an attempt to determine i t there

1s a relation between degree ot malignancy and the
toxohormone content 01' malignant tissue, the effect
of injected toxohormone, extracted from human malignant neoplasms, on blood plasma iron concentration was
studied in mice.

CHAPTER II
REVIh~

A.

OF LITERATURE

Enzymatic Tumor-Host Relations and
a Cancer Toxin

I~pothesis

of

Blumenthal and Brahn (1910) and Brahn (1916)
reported that the liver cB.talase activity of cancerbearing patients was "remarkably low" as compared with
that of patients with other diseases.

Similar results

were obtained by Rosenthal (1912) during his stUdies
on tumor-bearing animals, and he hypothesized that
some toxic SUbstance might be produced in tumor tissues
to decrease the liver catalase activity.
Buckley (1921) stated in his text on cancer
that an abnormal hormonal secretion of cancer cells
exerted an adverse influence on the body systems because he had observed that the "condition" of the
blood was found to be improved temporarily after

th~

surgical removal of a cancerous mass.
It was conclusively demonstrated by Greenstein
and co-workers (Greenstein, Jenrette, and White, 1941;
Greenstein and Andervont, 1942, 1943) that the liver
catalase activity of cancer-bearing animals was significantly lower than that of normal animals and

-3-

-4specifically attributable to the presence of a growing
tumor and not to any secondary cause to which the
tumor's presence may give rise.

In these articles

Greenstein et ale reported the following: the activity
of catalase was by far the most affected ot all the
individual enzyme systems studied in the livers of
mice and rats with a wide variety ot malignant tumors,
the decrease in liver catalase activity was progressive with growth of the tumor, the effect of the tumor upon the activity of this liver enzyme was found
to be reversible upon removal of the tumor, the decrease was due only to the tumor and not to any growing tissues present in the animal, and the decrease
was always present in cancer-bearing animals.

These

observations subsequently led Greenstein (1947) to
state that a tumor may produce the systemic effects
noted by giving off same toxic product to the circulation.
B.

Toxohor.mone

1.

Discovery and FUndamental Characteristics
In 1948 Nakahara and Fukuoka, using liver cata-

lase activity as a criterion for bio-assay, demonstrated that a substance which was extracted from
human cancerous tissue with water and then prebipitated

-5with alcohol after removing heat-coagulable material
was capable of significantly decreasing liver catalase activity beyond the normal limits of variability
after twenty-four hours when injected into mice.

In-

jections of fifty to one hundred milligrams of the
sUbstance produced an average depressed liver catalase activity, expressed in cubiC centimeters of
oxygen liberated from hydrogen peroxide, of

4.3.

Nor-

mal mice were found to have an average liver catalase
activity of 8.0.

Positive results were obtained from

all malignant tissues used, carcinoma as well as sarcoma, primary as well as secondary or metastatic, and
surgical as well as autopsy materials; it was clearly
distinguishable from similarly prepared fractions of
normal tissues and normal tissue necrosates which had
no special depressing effect on liver catalase activity !a!!!2 (the average activity was found to be
between

7.2 and 7.5 cubiC centimeters of oxygen after

injections of these fractions); and it exhibited no
inhibiting action on crystalline catalase !B vitro.
The substance was called "toxohorm.one" by the investigators to express its supposed biological status
of being a cell-produced substance which is released
into circulation and which produoes a olearly definable

-6.
biochemlcal lesion in a target orgs.n.
o~

They conceived

it as being the pathological counterpart

mones.

o~

hor-

Variations demonstrated in the activities

or

dif'f'erent samples or trle extrB.cted material led
Nakahara to hypothesize that there might be a relation
between histological character and toxohormone content of malignant tissue, but he was unable to demonstrate this supposition.
The original work done by Nakahara and Fukuoka
wa.s confirmed and substantiated by Gree ntield and
Meister (19$1).
that
areas

It was also shown by these authors

~ractions ~rom
o~

the necrotic and non-necrotic

a malignancy produced reductions of' liver

catalase activity
(between a

40

o~

and a

about the same magnitude in mice
4l~

per cent reduction rrom nor.

mal).
Endo at &1. (1955) demonstrated that toxohormone and a substance extracted
by Hargreaves and Deutsch

~rom

malignant tissue

(1952) which inhibited

(the Kochsaft f'actor) were entirely different entities
-

liver ca.talase activity in vitro but not in vivo

since toxohormone inhibited liver catalase activity
in vivo
vitro.
- but not -in ...................
It has been demonstrated by investigators that

-7"toxohormone fractions" prepared from samples of normal tissues such as liver, spleen, kidney, and whole
skinned animal homogenates produce very little if any
decrease in liver catalase activity (Greenfield and
Meister, 1951; Nakagawa, Kosuge, and Tokunaka, 1955;
Kampschmidt, Adams, and McCoy, 1959; Fujii, Rawachi,
Okuda, Haga, and Yaroatuura, 1960).
As stated by Nakahara and Fukuoka (1958), in a
review of related literature, all the malignant tumors
which have been tested, human and animal, have yielded
a liver catalase-depressing fraction (toxohormone).
This is in direct accord with the fact that significantly decreased liver catalase activity has been
found in all animals bearing malignant tumors.

The

following is a list of the tumors which have been
investigated: human carcinomas of the stomach, rectum,
colon, bladder, and breast; human lymphosarcoma;
human mammary fibrosarcoma; mouse marrnnary sarcoma; rat
fibrosarcoma; Brown-Pearce carcinoma; chicken sarcoma; human hepatoma; rhodamine sarcoma, and Walker
carcinosarcoma.
Paralleling experimentation on toxohormone,
Adams (1950, 1951) found that injections of whole
homogenates of both mouse sarcoma and carcinoma pro-

-8duced depressions of liver catalase in mice, and he
inferred that the depression was due to the release
of toxic material from the injected tumor homogenates.
He also demonstrated that the injection ot homo-

genates of a variety ot

no~~al

tissues produced no

significant catalase depressions.

;'

Lucke at al.

(19$2), using parabiotic rats, showed that the liver
catalase activity in the non-tUMor-bearing partner
in the parabiotic union was reduoed to the level

ot

single rats bearing the tumor, and he interred that
a humoral transmission ot some agent from the turrl,o:r
was responsible.
Further evidence in support ot the validity

at the liver catalase-depressing factor
and Fulruoka has

gators.

bef~n

Kamp8c~~idt

01'

Nakahara

demonstrated by other investiet 81. (1959) reported that

injections ot one hundred milligrams of an alcoho1precipitable extract ot Walker carcinosarcoma 256
depressed the liver catalase activity ot rats aftar
twenty-tour hours tram a normal level ot
lase units to 3150 catalase units.

5400

cata-

Fujii et al.

(1960) reported that injections ot twenty milligrams
ot a plcric8.cid-hydrochloric acld-alcohol-Prec1pltable
extract ot both human hepatoma and rhodamine sarcoma

-9reduced the liver catalase activity of mice approxtmately fifty and sixty per cent respectively.
2.

Purification
Although some research has been done on the

purification of toxohormone (Nakahara and Fukuoka,

1950, 1954; Fukuoka and Nakahara, 1953; Nakagawa,
Kosuge, and Tokunaka, 1955; Ono, Sugimura, and Umeda,

1955, 1956), the precise chemical nature of taxohormone has not yet been elucidated.

Nakahara and

Fukuoka (1958), in a summation of the present concepts, state that in its elementary form it is probably a polypeptide of rather small molecular size.
It probably occurs in cancerous tissue either as
aggregates of the elementary form or in close association with some other substance, possibly nucleic
acid; it occurs in both a dialyzable and non-dialyzable
form, the former being derived from the latter when
digested with papain or pepsin.

The enzymatic action

which yields the dialyzable form may simply dissociate the nucleic acid from the elementary

fo~.

3. Mode of Action
The mode of action of toxohormone has also come
under the investigation of researchers (Fukuoka and
Nakahara, 1951, 1953; Ono, Umeda, and Sugimura, 1956;

-10.

Ono, Ohashi, Bnd Yago, 1960).
stated

th~t

Nakahara (1960) has

the outstanding changes observed in

eEl.ncer-bearing animals seem to be specifically related
to disturbances in iron metabolism, and these changes
have been elucidated in normal animals by the injection of toxohormone-containlng tumor fractions (Nakahara
and Fukuoka, 1949; Greenfield and Meister, 1951; Ono,
Umeda, and Rugimura, 1956; Roshlz1ma, 1957; Kampschmidt,
Adams, and McCoy, 1959; Fujii, Kawachi, Okuda, Haga,
and Yamamura, 1960).

He suggests that the production

of decreased liver catalase activity, increased liver
protoporphyrin" and decreased liver ferritin and
blood plasma iron by injections of toxohormone as
described in these articles are closely related phe ...
nomena and as such speak strongly for the implication
of toxohor.roone in the disturbed iron metabolism of
cancer-bearing animals.
other changes present in cancer-bearing animals
and brought about by injections 01' the active tumor
traction (toxohormone) but not related to iron metab.
olism have been observed.

Fukuoka (1952) demonstrated

thymus involution in toxohormone-injeeted

anL~alsJ

and

Ono (19$9) demonstrated the depression of diphosphopyridine nucleotide synthesis in the liver of injected

-11-

animals.
C.

Tumors, Toxohormone, and Blood Plasma Iron Relations
One ot the .first reports in the literature

concerning the relationship of tumors and blood plasma
iron concentration was that at Hei1meyer and Plotner

(1937) who reported that the plasma iron level in
cancer-bearing animals was "low".
Postiglione (1946). Yanagisawa (19S5),

and

11jima (1956) all repopted that the plasma iron concentration in caneer patients was considerably decreased (Sugtmura, 19S7).
Sugimura (19S7), investigating the distribu-

tion ot radioaotive iron inJeoted into tumor-bearing
rats, noted that the concentration at iron in the
plasma ot theae anbnals was decreased
,30

approxtmatel~

per cent.
Kam'Psc~JMldt

at ale (1959) reported that

I~

jactions at toxohormone-contaln1ng material produced
a pathological alteration in the blood plasma iron

concentration ot rats.

The iron level was reduced

from an average normal concentration of 281 ltlicrograms

per one hundred mIlliliters to an average of eighty-1'Dur
micrograms per one hundred millIliters e1ght hours
after single injections of 0.10 milligrams of an

-12alcohol-preoipitable extract ot Walker oaroinosarooma
2$6 prepared after the method of Nakagawa et ale (1955).
Injeotions of one hundred milligrams of the same
material produoed a reduction from an average plasma
iron oonoentration of 294 miorograms per one hundred
milliliters to sixty-two miorograms per one hundred
milliliters after twenty-four hours.

This same study

revealed plasma iron to be 250-500 times as sensitive
to toxohormone as liver oatalase.
Fujii et a1. (1960) showed that the plasma iron
level of rats was signifioantly reduoed from an
average ot ninety-three micrograms per one hundred
milliliters to an average of

approx~nately

fifty

micrograms per one hundred milliliters within twelve
hours following intraperitoneal injections of five
milligrams of toxohormone-oontaining material (piorio
aoid.hydrooh1oric aoid-alcoho1 precipitate) extracted
from human hepatoma.

CHAPTER III
MATERIALS AND MRL'HODS

A.

Preparation and Injection of Tumor Fractions
Frozen biopsy specimens of seven malignant

neoplasms were obtained from Cook County Hospital,
Chicago, Illinois.

They consisted of the following

tumors as determined through histological examination
by members of the Department of Pathology of that

hospital: one adenocarcinoma, rectum; four adenocarcinomas, colon; one adenocarcinoma, breast; and
one anaplastic carcinoma, bronchiogenic.

The turaor

samples were maintained in a frozen state until they
were homogenized.
Homogenization and extraction or fat from each
of the seven tumor specimens was accomplished similarly to the method

01'

Fujii et ale (1960).

No attetapt

was made to further purify the remaining material
by reprecipitatlon since it had been demonstrated by
other investigators that plasma iron concentration is
very sensitive to small amounts of to:X:ohorrllone, and
it was relt that even small amounts ot' this crude
toxohormone-containing material would depress mouse

-13-

plasma iron concentration enough so that
comparisons could be :made.

~dequate

The method used is out-

lined as follows:

1) Approxtmately two grams ot frozen tumor
tissue was homogenized with approxhnately
ten volumes ot acetone in a Potter-Elvehjem
homogenizer suspended in an ice-water bath
to minimize frictional heating ot the
sample.
2) The suspension obtained was oentrituged
at tive thouaand R.P.M. tor ten minutes
and the tat-containing supernatant decanted
and discarded.
)

The protein-containing precipitate was

washed with acetone, dried in air, and

preserved in a freezer until needed tor
injection.
EXpertmental animals employed in all instances
were young male albino mice at a homogeneous strain
weighing approximately twenty to twenty-tive grams.
Upon reoeipt they were transterred to standard mouse
cages and maintained on a diet ot Wayne Lab-Blex and
adequate water supply.

In most instances the antmals

were allowed to remain at least two and not more than

-15ten days in their cages before experimentation.

Their

weight was found not to vary more than plus or minus
three grams during their repository period.
At the time of injection, one hundred milligrams of the dried tumor fraction, containing the
total protein component, were mixed with

2.5

milli-

liters of 0.9 per cent sodium chloride solution.
Employing a two cubic centimeter tuberculin syringe
armed with a twenty-five gauge needle,

0.5

of a mil-

liliter of the saline-tumor fraction suspension, containing twenty milligrams of the tumor fraction, was
injected intraperitoneally into each of five mice.
The injected mice were maintained in a normal
environment on the pre-injection diet and, by pooling
plasma, two determinations of the collective blood
plasma iron concentration made twenty-four hours after
injection (Table VII).
All seven tumor specimens were tested utilizing
seven groups of five mice per group.
B.

Blood Plasma Iron

Dete~ination

The method employed for the detennination of
blood plasma iron concentration was derived from the
method ot Kitzes, Elvehjem, and Schuette (1944).
Neither their method nor any other method reviewed

-16(Barkan and Walker, 1940; Peters, Giovanniello, Apt,
and Ross, 1956) could in entirety be used for plasma
iron determination in mice since the

vol~~le

of plasma

required in these procedures (2.5 mI.) could not bo
obtained from any one mouse, the initially intended
number to be used per determination, or consistently
from groups of five mice, the number finally employed
in this investigation.

The amount of plasma that

could be obtained from anyone mouse varied from
0.2 to 0.7 of a milliliter.

Volumes below 0.6 of a

milliliter were obtained 80 per cent of the time.
Initially, as mentioned above, plasma iron
determinations were attempted on Single normal mice,
but sufficient plasma volumes necessary for the adopted
method could not be consistently obtained.

Furtller-

more, the results showed a fluctuation in the nor.mal
range of values so extensive as to prevent any suitable
comparisons among single mice (Table V).

Because

of these reasons, plasma was pooled in equal volumes
from each of five mice for every determination of
blood plasma iron, thereby insuring a sufficient plasma
volume and decreaSing the standard deviation.

No

more than five mice per group could be used because
of the limited amount of tunlor tissue available.

The

-17procedure is outlined as follows:
1) By means of cardiac puncture, approxtmate1y
one rol. of blood was obtained from each of
five mice, lightly anesthetized with ether.
A twenty-five gauge needle was used on a ten
cubic centimeter glass syringe coated with
a solution of 0.1 molar sodium oxalate.
The blood samples were transferred to five
five-milliliter semi-micro centrifuge tubes,
respectively.
2) The oxa1ated blood samples were centrifuged
at 1550 R.P.M. tor ten minutes.

3) The plasma was separated from the blood cells
by means ot a

pipette.

dro~per

One-tenth

of a m1. was obtained trom each ot the five
plasma samples and transferred to another
tive ml. semi-micro centrifuge tube.

4)

Two-tenths of a m1. of distilled water was
added to the 0.5 of a

mae

of pooled plasma

and the tube was placed in boiling water
tor two minutes.
5) Two-tenths ot a m1. ot

25 per cent tri-

chloroacetic acid was then added, the
mixture stirred thoroughly and centrifuged

-18at 1550 R. P.l'1. for ten minutes.
6) The clear protein-tree supernatant was de-

canted into a tive ml. graduated test tube
and the volume was noted.
7)

01stilled water was added to the 1'I·ec1p1tate in an amount equal to the d:U"ference

between the noted volume 01' the supernatant
and 1.2 rol.

The precipitate was broken up,

stirred well, and the tube was centl"1.tuged

1550 R.P.M. tor ten minutes.

at
8) The

roeeultant supezanatant was decanted into

the previous supernatant and distIlled
water added, i t necessary, to make 1.2 ml.
9) The

following were added to the tube Con-

taIning the clear supernatants:
a) 0.05 01' a ml. 01' undIluted thioglycolic
acid

b)

O.os

01' a ml.

at 5 per cent a,a '-dipyrldyl

c) 0.2 01' a m1. of 25 nor cent sodium citrate
The contents were mixed.

10) The resultant 1.5 mI. pink solution was
transterored to a microcuvette, and after
tifteen minutes its absorbance at 508

mp

was roead on a Beckman Junior Spectrophotonleter

-19-

which had been adjusted to the zero reading .
with distilled water.
11) The concentration of blood plasma iron was
calculated by using a previously prepared
standard curve which plotted concentration
of iron against absorbance (Figure 2).

The

actual value as obtained from the graph
was multiplied by a factor of two since only

0.5

of a ml. ot plasma was used, and the

graph was based on values obtained from one
mI. ot standard iron solutions.
Two

dete~inations

were run on each sample of

pooled plasma.
The reagents were tested for each group of
determinations made by performing a determination on
a known iron concentration and comparing the result
with an originally obtained value.
Co-ordinates used in the preparation of the
standard iron curve were obtained by averaging the
absorbance readings obtained fram three determinations
performed on an iron-free solution and each of the
following six iron concentrations derived fram a
standard iron solution: 30, 60, 90, 120, 180, and

240 micrograms per one hundred milliliters (Table I).

-20-

The concentration

rL~e

was adopted fram nor-mal rat

plasma iron levels as reported by Kampschmidt at a1.
(19$9).

Jete:rminationa were run in the following

manner:
1) Two-tenths of a ml. of 25 per cent tr1chloroacetic aoid, 0.05 of a ml. of

~~

diluted thiog1yoollc acId, 0.05 of a ml.
of $ per cent a,a'-dipyridyl, and 0.2 of
a ml. ot

25

per cent sodium citrate were

added to one rul. of distilled water containing a known oonoentration of Iron.
2) The resultant 1.$ ml. solution was trans-

ferred to a microcuvette and after fifteen
minutes its absorbance at

SO~

mp was read

on a Beckman Junior 3pectrophotatlleter
which had been ad3usted to the zero reading
with distilled vater.
The equation

~or

the linear curve used in plot-

ting conoentration against absorbance was calculated
from the statistical method ot "least squares It (Batson,
1960) (Figure 1).

Normal blood plasma iron ooncentration and
standard deviation were obtained by performing the
afor$mont1oned plasma iron determination on seven

-21-

groups of five mice per group. averaging the results,
and applying a standard statistical method for determining standard deviation (Page and Culver, 1961)
(Table VI).
The precision and accuracy of the adopted
method was determined and evaluated for the standard
iron solutions and plasma by recovery experiments
and by experiments dealing with reproducibility of
results (Tables II, III, and IV).
C.

Determination of .Degree of lJfalignancy
Histological sections prepared from the tumor

specimens used were obtained from Cook County Hospital,
and a comparison of the degree of malignancy of each
of the seven tumors was made using the histopathological characteristics ot: anaplasia, increased
number of mitotic figures, nuclear hyperchromatism
and increased nucleocytoplasm ratio, and loss of cell
polarity.

Each of the four histopathological char-

acteristics were assigned values fram one to three;
three being the number used to indicate the greatest
relative anaplasia, nuolear hyperchromatism and size,
number of mitotic figures, or loss of polarity in
relation to the other neoplasms.

The mitotic index

was determined by counting the number of mitotic

-22figures in ten high power fields.

The tumors which

had the greatest sum total of values were considered
to be the most malignant (Boyd, 1953) (Table VIII).

OHAPTER IV

FINDINGS
The findings have been placed in chronological
order as an aid to understanding the investigative
process used to arrive at the conclusions presented.
The yield of dried precipitates obtained from
the extraction of the protein component of approximately two grams of each of the seven tumors employed varied in weight from 115 to 200 milligrams.
Table I lists the average and individual absorbance figures obtained fram colorimetric determinations performed on known iron concentrations and
an iron-free solution.

The range of absorbance

values,.018 through .180, was of necessity low and
narrow since the related iron concentrati.on range
desired, zero through 240 micrograms per one hundred
milliliters, was similarly characterized.

However,

even in this range it was found that readings could
be made quite accurately on the Beckman Junior Spectrophot ometer.
The co-ordinates used in the preparation of
the standard iron curve were obtained fram the

-23-
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TABLE I
ABSORBANCE READINGS OF KNOWN IRON
CONCENTRATIONS
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TABLE I

meg./100 1111.
0
30
60
90
120*
180
240
*See Table II

A1

A2

A3

A
Average

.017
.0~3
.0 1
.083

.019
.041
.065
.080

.018
.044
.060
.077

.139
.180

.138
.175

.1 5

.018
.043
.062
.080
.099
.139

.1~O

.180

figures presented in Table I: the!. component was
given absorbance values, and the
given concentration values.

Z component

was

The plotted points in-

dicated a linear curve, and the statistical equation
shown in figure 1 was used to calculate the straight
line.

Figure 2 is a representation of the standard

iron curve used.

The curve does not origina.te at

zero since the spectrophotometer was adjusted to
zero with distilled water and the first reading
made with distilled water plus reagents.
Since the method used to determine blood plasma
iron concentration was a new one, tests were run to
dete~ine

its preCision and aocuracy.

The preCision

ot a method depends upon reproducibility of results,
and in general, the standard deviation of a set of
values trom a set ot deter.minations upon the

s~e

material 1s a measUl'ement ot the reproducibility ot
a measurement (Pase and Culver, 1961).

The method

used to determine the standard deViation ot results
obtained fram a standard iron solution was the performance of absorbance measurements on several 81iquota fram that solution and solving the statistical
equation,

(J:

YF~::(~

: f12 J.

The standard devia-

tion was found to be plus or minus .0028 units
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EQUATION:

1\

X

= X + b (Y

- Y)

where:

1\

X is the expected value of X at a
given value of Y,
X is the mean of the observed values
of X,
b is the slope of the line computed
as: LXy
where:
L.y2
L.xy
Ly2

=

LXY - ( ~X) ( l l )

-

"2.y2 -

n

( LY)2
n

Y is the mean of the given values
of Y
A

X

-

21.0

+ O.66Y

FIGURE 1.
STRAIGHT LINE EQUATION
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240

200

160

meg./IOO ml.

120

80

40
o

o

.020

.060

.100

ABSORBANCE

FIGURE 2.

STANDARD IRON CURVE

.180

-28.
(2.8 adjusted).

The coerficient or variation was

2.8% (Table II).

The standard deviation or measure-

ments on plasma was found to be plus or minus 3.46
and was determined by performing duplicate iron concentration measurements on each one of a number of
plasma speclmens and solving the equation,
(Table III).

~= ,j~~2

In general, the permitted variations

for clinical chemistry tests are limits or errors
based on plus or minus

3~or

upon a coefficient of

variation of plus or minus 2-3% (Page and Culver,
1961).

The accuracy of the adopted method was deter-

mined for plasma by the performance of recovery experiments.

A known amount of iron was added to

one-half of a divided plasma sample and the divided
samples quantitatively analyzed for iron.

In this

manner the percentage of added iron recovered could
be determined and used to assess the accuracy of the
method.

The average amount recovered was 96.8% as

shown in Table IV.
As indicated in Chapter III, determinations
of pla3ma iron concentration were attempted on single
mice, but sufficient plasma volumes could not be
consistently obtained.

Furthermore, the dispersion

of normal values, as measured by standard deViation,
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TABLE II
REPRODUCIBILITY OF RESULTS USING AN
IRON SOLUTION
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TABLE II

Concentration of Iron Solution
120 mcg./100 ml.
ALIQUOTS(n)

ABSORBANCE(x)

#1
#2

.097

.102

$~

.094
.097

#5
#6

.100
.102
.100
.101

#7
#8
#9
#10
#11

.096

.102

.097
MEAN(x) :: .099

STANDARD DEVIATION!

IT) : Vr~=!X_

-1i. )2,

tr

=!

.0028

--

COEFFICIENT OF VARIATION(C.V.) - tr 100%

a.v. ::

2.8%

J
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TABLE I I I
REPRODUCIBILITY OF RESULTS USING
PLASMA
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TABLE III

PLASMA IRON CONCENTRATION
OF DIVIDED SAMPLES
mcg./100 ml.

PLASMA SAMPLES(n)

(a)

(b)

258

3

258
262
234

5

240

246

1
2

4

228

STANDARD DEVIATION(cr)
cr

=yL:,2
:!

3.46

254

238

222

where: d : dirference
between duplicates
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TABLE IV

RECOVERY OF ADDED IRON
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TABLE IV

DIVIDED

PLASMA SAMPLES

Fe ADDED

Fe FOUND

meg.

meg.

#1 Human a)
b)
......
.........
112 Ifuman a)

-_

_-

0
0.9
.........

--

-

_----

-

ADDED Fe
RECOVERED -

%

0.40
104 .....
..........1.34 ..... _-----0
0.58
b)
0.9
1.44
....'- .. ......
.... - ......... ---_ .... 96 ... -.-#3 Mouse a)
0
1.05
b)
0.9
1.90
94
... - ....... --- ...... _-- ... .. ... ...
#4 Mouse a)
0
1.18
b)
0.9
2.02
93
...
................... .... --------- ......
#5 Mouse a)
o
b)
0.9
97

... -

-------

_

__

----

_-

_ _ _ _-------_
Average

= 96.8%

-32was considered too extensive to permit an adequate
comparison of toxohormone activity utilizing the
criterion of plasma iron concentration.

The mean

plasma iron level for single normal mice was found
to be 246 micrograms per one hundred milliliters
with a standard deviation of plus or minus 21.0
micrograms (Table V).

The standard deviation and

mean iron concentration of plasma pooled from seven
groups of five normal mice per group were then determined.

The mean was 249 micrograms per one hun-

dred milliliters, and the standard deviation was plus
or minus 10.63 micrograms which was considered acceptable for making adequate comparisons (Table VI).
The injection of twenty milligrams of the
toxohormone-containing tumor fractions produced no
apparent visual effects in the mice, nor did any of
them die prior to the determinations of blood plasma
iron concentration.

As mentioned previously, two

determinations were made on each sample of pooled
plasma obtained from five similarly injected mice,
and the results were averaged.

Table VII shows the

tumors from which the injectable materials were obtained and the average resultant plasma iron concentrations which ranged fram 125 to 212 micrograms per
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TABLE V
VALUES, MEAN, AND STANDARD DEVIATION OF PLAS}!I,A IRON

CONCENTRATION AMONG SINGLE NOm{AL MICE
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TABLE V

PLASMA IRON CONCENTRATION(x)

meg./100 ml.

MOUSE(n)

#1
#2

256
262
2)6
225

~
#5

244

116

210
236
284
270
230
266
228
250

#7

#8
#9

#10
#11
#12
#13
MEAN(i) ':

246

meg./IOO ml.

STAIIDARD DElTIATION(o-) "
tT

:

vi[

L ~x_-

/12 ]

~ 21.0

COEFF'ICIENT OF VARIATION(C.V.)

C.V.

=

-x

:

(T

lOO~

8.5%
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TABLE VI
VALUES, MEAN, AND STANDARD DEVIATION OF THE IRON
OONCENTRATION OF PLASMA POOLED FROM
GROUPS OF FIVE NORMAL lUCE
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TABLE VI

PLASMA IRON CONCENTRATION(x)

meg./100 ml.

GROUPS(n)

236
252

1
2

240

3

~6

264

7

262

~~

MEAN(x)

= 249

meg.1 100 ml.

STANDARD DEVIATION( crl
(T

:

y[

L.~x_- 1X f

:!

10.63

COEFFICIENT OF VARIATION( C. V .)

= r:r 100%

x

-

a.v. -

4.2~

J
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TABLE VII
POOLED BLOOD PLASMA IRON CONCENTRATIONS OF
GROUPS OF FIVE 1-1ICE INJECTED WITH
TUMOR FRACTIONS
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TABLE VII

TUMOR

AVERAGE
PLASMA IRON CONCENTRATION
mcg./100 m1.
(a) (b)
Average

1) Anaplastic
carcinoma,
bronchiogenic
(279-63)

172

116

174

2) Adenocarcinoma,
breast
(6339-63)

200

204

202

3) Adenocarcinoma,
colon
(14187-6,3)

128

122

125

164 170

167

5) Adenocaroinoma,
oolon
(8719-63)

208

216

212

6) Adenocaroinoma,
reotum
(6673-6,3 )

180 174

177

7) Adenocaroinoma,
colon
(282-63)

212

208

210

4)

Adenocarcinoma,
colon
(9741-63)

one hundred milliliters.
Periodic testing of the reagents revealed
them to be stable throughout the investigation and
capable of giving consistent results.
To compare the toxohormone activity of the
seven malignant tumors employed, a granh was prepared
Which showed the resultant blood plasma iron concentrations of seven groups ot tive mice per group injected with the toxohormone-containing tumor tractions.
The plus or minus 10.63 standard deviation of plasma
iron concentration obtained trom the groups ot five
nor.mal mice was utilized in the preparation of the
graph.

This measure of dispersion includes both

the normal spread of plasma iron values and the inherent laboratory errors.

The graph depicts three

distinct and separate groups into which the resultant
plasma iron concentrations may be divided.

The nor-

mal plasma iron concentration was also included for
comparison (Figure 3).
A comparison of the degree of malignancy of
each ot the seven tumors was made.

As indicated in

Chapter III, values fram one to three were assigned
the four histopathological characteristics utilized;
three indicating the greatest relative degree ot

NORMAL PLASl"lA
IRON CONCENTRATION

TUMOR

~
~

ADENOCARCINOMA, COLON

8719-63
ADENOCARCINOMA, COLON

282-63

ADENOCARCINOMA, BREAST

6339-63
ADENOCARCINOMA, RECTUN

6673-63
ANAPLASTIC CARCINOMA,
BRONCHIOGENIC

279-63

ADENOCARCINOMA, COLON

9741-63

ADENOCARCINOMA, COLON

STANDARD
DEVIATION

14187-63
110

170

130

190

210

PLASMA IRON CONCENTRATION
meg./I00 m1.
FIGURE 3.

1'mIOR : PLABIA IRON COICEl'fRAtIOB

230

250

-38malignancy.

The sum total of the histopathological

values was then calculated for each tumor and the
comparison was made.

The adenocarcinoma of the

breast (6639-63) and the adenocarcinoma of the colon
(282-63) were found to be the most malignant.

Two

adenocarcinomas of the colon {14l87-63 and 9741-63}
were found to be the least malignant (Table VIII).
As mentioned in Chapter III, tumors with the greatest
sum total of histopathological values were considered
to be the most malignant, and conversely, tumors with
the least sum total of values were considered to be
the least malignant.
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TABLE VIII
COMPARISON OF DEGREE OF

~ALIGNANCY
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TABLE VIII

TUMOR

A.

(M. I. )

Adenocarcinoma,
breast (6339-63)

3

(12)

Adenocarcinoma,
co1on(282.63)

3

Anaplastic carcinoma,
bronchIogenic (279.63) 3
Adenocarcinoma

N.H.&S.

P.

3

3

3

12

(13 )

3

2

3

11

(5)

1

2

3

9

l-i.

TOTAL

colon(8719-63~

2

(5 )

1

2

2

7

Adenocarcinoma,
rectum(6673-63)

2

(6 )

1

2

2

7

Adenocarcinoma,
colon(14187·63)

1

(6)

1

2

1

5

2

(4 )

1

1

1

5

Adenocarcinoma

colon(9741-63~

'* A.

- Ana'Plasia

(M.I.) - Mitotic Index

M. - Number of Mitotic Figures
N.H.&S. - Nuclear Hyperchromatism and Nucleocytoplasm Ratio
P. - Loss of Polarity

CHAPTER V

DISCUSSION
The method adopted for the quantitative measurement of iron in small volumes of blood plasma was
found to be precise, accurate, and reliable for the
investigation conducted.
Although the range or dispersion of normal
plasma iron levels was reduced by pooling blood from
groups of five twenty-five gram male mice, it is suggested that even larger groups of mice of this weight
be used to further reduce the standard deviation if
very precise comparisons of plasma iron values are
to be made.

For this investigation, however, the

range obtained was suitable for adequate comparisons
of the plasma iron levels produced by injectable
tractions extracted from different tumors.
From results obtained it may be stated that
intraperitoneal injections of twenty milligrams of
the similarly prepared total protein-containing
fractions extracted fram each of the seven human
malignant tumors tested produced definite decreases
in the blood plasma iron concentrations of young male
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-hlmice after twenty-four hours.

This is in agreement

with the results of other investigators who have
studied the effects of protein-containing tumor
fractions on blood

~lasma

iron concentration

(Kampschmidt et al., 1959; Fujii et al., 1960; Ono
at al., 1960).

Also in accord with results obtained

by these investigators is the fact that plasma iron
appears to be quite sensitive to the substance causing
its depression since the injection of only twenty
milligrams of the crude protein-containing fraction
used in this investigation produced substantial depressions; as much as

50

per cent in one instance,

although the average was a 30 per cent decrease.

How-

ever, this research problem was not specifically
undertaken to show that a fraction of malignant tissue
produces unique systemic changes when injected into
laboratory animals.

It has been well demonstrated

by other investigators that a eharacteristic, toxie,
protein or prote1n-like substance, called"toxohormone",
is produced by malignant tissue, and is responsible
for certain systemic changes, including that of decreased blood pla8ma iron concentration, when injected into laboratory animals.

This knowledge has

been used as a premise upon which this investigation

-42was based, and the findings presented which demonstrate a decrease in the normal plasma iron concentration after injections with malignant tumor fractions serve only to help elucidate this knowledge
without attempting to prove its veracity.
Interpretation of the findings, in view of the
purpose of this research, seam to justify the following conclusions.

It the graph presented in figure

3 is analyzed, it is apparent that the resultant
decreased plasma iron concentrations, induced in mice
by similar injections of the protein-containing fraction of malignant tumors, can be divided into three
distinct groups which are not connected by any limits

ot the standard deviations.

It is therefore possible

to divide the seven human malignant neoplasms investigated into three unrelated groups in reference to
their effect on plasma iron concentration and to
conclude that various individual tumors among the
seven produce varying amounts of the substance which
causes this effect, presumably toxohormone, or that
the SUbstance produced may be more systemically
toxic in some instances.

Furthermore, if the relative

degree of malignancy of each of the tumors is compared
with the related plasma iron depressions induced by

them, it p;enerally apnears that

or

tbe seven human

malignant neoplasms tested, the most malignant tumors
produced the least depression or plasma iron, and
conversely, the least malignant tumors produced the
greatest depression

or

plasma iron, (Table IX).

If

the bronchiogenic anaplastic carcinoma is excluded,
being a different type of tumor than the other six,
the picture is made even clearer.

Thererore it

would seem that the more malignant a tissue is the
less toxohormone it produces.
viewed in light

or

Ir this hypothesis is

Greenstein's (1955) idea that a

substa.nce which is a toxin In a turnor due to abnormal
production may only be a normal regulator

or

metabolic

processes in normal tissues, it is conceivable that a
tumor which more closely resembles normal tissue,
although possessing an exaggerated metabolism, may
produce greater amounts

or

this "regulator" (toxo-

hormone) than the tumor with a high degree of malignancy which may be mostly adapted to growth a.nd as
such has lost or altered its biochemical mechanism
to produce this "regulator" in large amounts.

How-

ever, before this hypothesis could be stated as a
theory for malignant tissue, greater numbers of the
same type of malignancy trom the same organ would
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TABLE IX

COMPARISON OF RELATIVE DEGREE OF MALIGNANCY
WITH RELATED PLASMA IRON DEPRESSIONS
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TABLE IX

AVERAGE
PLASMA IRON
CONC.
mcg./100ml.

VALUES DENOTING
RELATIVE
DEGREE OF MALIGNANCY
(From Table VIII)

breast(6339-63~

202

12(most malignant)

Adenocarcinoma"
colon(282.63)

210

11

Adenocarcinoma,
colon(8719-63)

212

7

TUMORS
(Grouped According
To Graph In Fig. 3)

.

Adenocarcinoma.

-~-~~---~~--~~-~~-~---~-~------

(Anaplastic carcinoma

bronchlogenic)(279-63~

(174)

(9 )

Adenocarcinoma-t
rectum(6673-63 )

177

7

Adenocarcinoma,
co1on(9741.63)

167

5

--------~~---~----~----~~--~-~-

Adenocarcinoma,
colon(14187·63)

125

5(least malignant)

-45have to be compared.

In addition, serial sections of

the tumors should be made for histopathological
examination since it is possible that a single section
may not be representative of the whole.

In this

project only six tumors were of the same type of
malignancy (adenocarcinoma) and only four of these
were from the same organ (colon).

The results ob.

tained from these four alone demonstrate minimal
but good evidence for the hypothesis presented.
No attempt was made to determine the total
protein content of the various samples of malignancies
employed since this was considered unnecessary for
this particular investigation in view of the fact
that the representative tumor samples were similarly
prepared and equal amounts of the dried fractions
injected, and it was not the purpose of this investigation to Compare toxohor.mone content with total
protein content.
In relation to this investigation, two other
questions remain to be answered; is toxohormone
characterized by different degrees of toxicity, and
do different types of malignancies produce varying
amounts of toxohormone or toxohormone of varying
degrees of toxicity?

CHAPT~~

SUMMARY AND

VI

CONCLUSIONS

An investigation was undertaken to compare
the toxohormone content ot human malignant tissues.
The tollowing seven human malignant tumors
were tested: tour adenocarcinomas, coloni one adenocarcinoma, breast; one adenocarcinoma, rectum; and
one anaplastic carcinoma, bronchiogenic.
The measurement ot blood plasma iron concentration in mice atter injections ot similarly prepared tractions ot these tumors served

8S

the means

by which comparisons were made.
Tumor tractions were prenared by homogenizing
two-gram trozen tumor samples with acetone, centrituging the suspension, and drying the resultant
precipitate in air atter decanting and discarding
the supernatant.
Por each ot the seven malignancies tested,
twenty milligrams ot the dried protein-containing
traction were injected intraperitoneally into each
ot tive twenty-tive gram male albino mice and, by
pooling plasma, two

spectro~hotometric
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determinations

-47of the collective blood plagma iron concentration
made twenty-four hours Hfter injection.

Groups of

five mice were utilized to decrease the normal dispersion of plasma iron levels and to obtain sufficient
plasma volumes for the determinations.
A new spectrophotometric method of determining
blood plasma iron concentration was developed for this
study since other methods reviewed required larger
volurrles of plasma than could be obtained.
Normal blood plasma iron concentration and
standard deviation were calculated tor plasma pooled
from five mice by performing the adopted spectronhotometric determination on seven groups of five normal
mice per group, averaging the results, and applying
a statistical method for determining standard deviation.
A comparison of the degree of malignancy of
each of the seven tumors was made using the histopathological characteristics of: anaplasia, increased
number of mitotic figures, nuclear hyperchromatism,
and loss of cell polarity.
The relative degree of malignancy of each of
the tumors was compared with the related plasma iron
depressions induced by their injected fractions.

-48..
The following conclusions seem to be justified
on the basis of the results of this study:
1) The adopted spectrophotometric method of
blood plasma iron determination appears to
be precise, accurate, and reliable for
utilization in this type of investigation.
2) The average normal blood plasma iron concentration of seven groups of five twenty.
five gram male albino mice is 249 plus or
minus 10.63 micrograms per one hundred
milliliters.

3) The blood plasma iron concentration of groups
of five young male mice was significantly
reduced twenty-four hours after single injections of twenty milligrams of similarly
prepared toxohormone-containing fractions
extracted from each of the seven human
malignant tumors tested.

Depressed plasma

iron values ranged from 125 to 212 plus or
minus 10.63 micrograms per one hundred milliliters.

4)

The plasma iron level of groups of young male
mice appears to be quite sensitive to the
effects of injections of even small amounts

-49of crude toxohormone-containing tumor fractions.

An average denression of 30 per cent

was observed.

5)

Various individual malignant tlImOrS among
the seven tested contained varying amounts
of toxohormone or toxohormone of varying
degrees of toxicity.

6) It generally appeared that of the seven mal!gnant tumors investigated, the more malignant
a tumor was the less toxohormone (or les8
toxic) it produced, and conversely, the less
malignant a tumor was the more toxohormone
(or more toxic) it produced.
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Photomicrograph 2
Adenocarcinoma, colon
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Photomicrograph 3
Anaplastic carcinoma, bronchiogenic
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Photomicrograph 2

Phot0.micrograph 3
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Photomicrograph
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Adenocarcinoma, colon
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Adenocarcinoma, rectum
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Photomicrograph 6
Adenocarcinoma, colon
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Photomicrograph 7
Adenocarcinoma, colon
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-59Reagents
1. Acetone
2. Powdered Pure Iron
3. Nitric Acid - 1:3
(25 ml. concentrated HNO)

4.

Hydrochloric Acid - 1:3
(25 mI. concentrated HCl

I

75 ml. distilled HOH)

I 75 mI. distilled HOH)

5. Standard Iron Solution - concentration of 0.1 mg/m1
a. 0.1 gm. of powdered pure iron dissolved by boiling
in 50 m1. 1:3 RNO) and 50 ml. 1:3 HC1. Some
material remained, probably ferric chloride, which
diss10ved in distilled HOH.
b. Dissolved iron diluted to one liter with distilled
HOB.
6.

25~

Trichloroacetic Acid • CC13COOB
(25 gm. TCA I 100 ml. distilled BOB)

7. 0.5~ a,a'.Dipyridyl - (2,2'.Bipyridine)
(0.25 gm. I 50 ml. distilled HOB)
a. Approxtmetely 3 m1. of 95~ ethyl alcohol should
be used to dissolve the material before distilled
HOH is added.
8. Undiluted Thioglycolic Acid - (Mercaptoacetic Acid) HSCH 2COOB
9. 25~ Sodium Citrate - Na3C6Hs07.2H20
(28.5 gm. / 100 ml. distilled HOR)
25 sm.
•
x
258.08 mol. wt. - '!!!'2~94"".~1~1~t-orm-.-wt"l"".
x

=

28.5 gm.

10. 0.1 molar Sodium Oxalate
(1.339 gm. I 100 ml. distilled HOn)
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